ABCB4 disease: Many faces of one gene deficiency
Jazyk angličtina Země Mexiko Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem, přehledy
PubMed
31759867
DOI
10.1016/j.aohep.2019.09.010
PII: S1665-2681(19)32262-8
Knihovny.cz E-zdroje
- Klíčová slova
- ABCB4/MDR3, Bile salts, Biliary cirrhosis, Cholestasis, Ursodeoxycholic acid,
- MeSH
- alely MeSH
- biliární cirhóza genetika MeSH
- cholagoga a choleretika terapeutické užití MeSH
- cholelitiáza genetika MeSH
- cholestáza genetika MeSH
- intrahepatální cholestáza genetika MeSH
- komplikace těhotenství genetika MeSH
- kyselina ursodeoxycholová terapeutické užití MeSH
- lékové postižení jater genetika MeSH
- lidé MeSH
- nemoci jater etiologie genetika MeSH
- nemoci žlučníku genetika MeSH
- nemoci žlučových cest genetika MeSH
- P-glykoproteiny nedostatek genetika metabolismus MeSH
- parenterální výživa škodlivé účinky MeSH
- věk při počátku nemoci MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
- přehledy MeSH
- Názvy látek
- cholagoga a choleretika MeSH
- kyselina ursodeoxycholová MeSH
- multidrug resistance protein 3 MeSH Prohlížeč
- P-glykoproteiny MeSH
ATP-binding cassette (ABC) subfamily B member 4 (ABCB4), also known as multidrug resistance protein 3 (MDR3), encoded by ABCB4, is involved in biliary phospholipid secretion, protecting hepatobiliary system from deleterious detergent and lithogenic properties of the bile. ABCB4 mutations altering canalicular ABCB4 protein function and expression may have variable clinical presentation and predispose to several human liver diseases. Well-established phenotypes of ABCB4 deficit are: progressive familial intrahepatic cholestasis type 3, gallbladder disease 1 (syn. low phospholipid associated cholelithiasis syndrome), high ɣ-glutamyl transferase intrahepatic cholestasis of pregnancy, chronic cholangiopathy, and adult biliary fibrosis/cirrhosis. Moreover, ABCB4 aberrations may be involved in some cases of drug induced cholestasis, transient neonatal cholestasis, and parenteral nutrition-associated liver disease. Recently, genome-wide association studies have documented occurrence of malignant tumours, predominantly hepatobiliary malignancies, in patients with ABCB4/MDR3 deficit. The patient's age at the time of the first presentation of cholestatic disease, as well as the severity of liver disorder and response to treatment are related to the ABCB4 allelic status. Mutational analysis of ABCB4 in patients and their families should be considered in all individuals with cholestasis of unknown aetiology, regardless of age and/or time of onset of the first symptoms.
Citace poskytuje Crossref.org
Morphological aspects of small-duct cholangiopathies: A minireview